Skip to content

Clinical performance and safety of soft contact lenses in children

Clinical investigation of myopia control contact lenses and spectacles in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN19818206
Enrollment
55
Registered
2025-10-13
Start date
2025-10-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia Eye Diseases

Interventions

The study will be a randomized, bilateral, 12-week crossover study comparing myopic control soft daily disposable contact lenses and spectacles in myopic children. Block randomization will be compute

Sponsors

CooperVision International Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To be enrolled, each participant shall meet the following criteria: 1. Age 8 to 12 years 2. They have no previous experience with contact lenses 3. The parent or guardian understands the study and rights of the participant and is willing to sign a statement of informed consent 4. The participant understands the study at a level appropriate for their age and is willing to sign a statement of assent 5. They are willing and able to follow the protocol

Exclusion criteria

Exclusion criteria: The following are specific criteria that exclude a candidate from enrolment in this study: 1. Ocular disorder that would normally contraindicate contact lens wear 2. Corneal refractive surgery or have an irregular cornea 3. Use of systemic or ocular medication that would contraindicate contact lens wear 4. Candidate is aphakic 5. Participation in a contact lens or lens care product trial in the previous 30 days

Design outcomes

Primary

MeasureTime frame
Intervention preference between spectacles versus contact lenses will be measured by asking subjects to provide their overall preferred intervention and the reasons for their choice using a 5-point Likert scale at the 12-week timepoint. In addition, where a participant selects the neutral option, a follow-up question will be asked to “force” them to decide. Reasons for their choice will also be collected.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Contacts

Public ContactJose;Philip Vega;Morgan

;

jvega2@coopervision.com;philip.morgan@manchester.ac.uk+1-925-640-2964;+44 (0)161 306 4441

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026